{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382262945636613641.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Aimee T. Broman"}],"foaf:familyName":[{"@value":"Broman"}],"foaf:givenName":[{"@value":"Aimee T."}]}],"career":[{"institution":{"notation":[{"@value":"From the Diabetes and Obesity Research Center (J.N., K.K.), Cardiovascular Pathobiology Program, Sanford-Burnham Medical Research Institute, Orlando, FL (L.L., T.C.L., O.J.M., R.B.V., D.P.K.); Department of Biochemistry (M.P.K., A.D.A.), and Department of Biostatistics and Medical Informatics (A.T.B.), University of Wisconsin-Madison, Madison, WI; and Duke Molecular Physiology Institute (T.R.K., R.S., O.R.I., D.M.M.), Departments of Medicine (T.R.K., D.M.M.), Pharmacology and Cancer Biology (D.M.M.)..."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362262945636613632","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1161/circheartfailure.114.001469"},{"@type":"URI","@value":"https://www.ahajournals.org/doi/full/10.1161/CIRCHEARTFAILURE.114.001469"}],"notation":[{"@value":"Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing Heart"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1161/circheartfailure.114.001469_VeaUUby05z6Uu6NhmucJ9wmeREr"}]}